How does pindolol improve antidepressant action?
- 1 May 2001
- journal article
- review article
- Published by Elsevier BV in Trends in Pharmacological Sciences
- Vol. 22 (5), 224-228
- https://doi.org/10.1016/s0165-6147(00)01682-5
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- β-blocker Binding to Human 5-HT1A Receptors in vivo and in vitro Implications for Antidepressant TherapyNeuropsychopharmacology, 2000
- Pindolol and Major Affective DisordersJournal of Clinical Psychopharmacology, 1999
- Antagonist properties of (−)-pindolol and WAY 100635 at somatodendritic and postsynaptic 5-HT1A receptors in the rat brainBritish Journal of Pharmacology, 1998
- Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonistsTrends in Neurosciences, 1996
- The selective 5-HT1A antagonist radioligand [3H]WAY 100635 labels both G-protein-coupled and free 5-HT1A receptors in rat brain membranesEuropean Journal of Pharmacology: Molecular Pharmacology, 1995
- Current advances and trends in the treatment of depressionTrends in Pharmacological Sciences, 1994
- Antagonism of the stimulus effects of yohimbine and 8-hydroxydipropylaminotetralinPharmacology Biochemistry and Behavior, 1993
- Structural analysis by the comparative molecular field analysis method of the affinity of β-adrenoreceptor blocking agents for 5-HT1A and 5-HT1B receptorsEuropean Journal of Pharmacology: Molecular Pharmacology, 1993
- 5-HT Receptors: Subtypes and Second MessengersJournal of Receptor Research, 1991
- Functional Correlates of Serotonin 5-HT1Recognition SitesJournal of Receptor Research, 1988